ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Urges Moratorium On Sale, Use of Silicone Breast Implants

January 10, 1992

Senate Vote On Override Of NIH Reauthorization Veto Delayed Until After US-USSR Summit Meeting

November 22, 1985

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

Compromise on 6,000 Grants Would Make NCI Payline Around 163-164: Natcher Committee Close to Markup

June 28, 1985

Trials Approved by NCI CTEP For the Month of March

March 30, 2012

DCT Board Approves Concept For BRMP Master Agreement

June 26, 1987